Inventor
PETERSON PER A
US33 patents
⚠️ This page may combine multiple inventors who share the name “PETERSON PER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCRIPPS RESEARCH INST
14 patentsUS6355479B1Mar 12, 2002
MHC class II antigen-presenting systems and methods for activating CD4+ T cells
SCRIPPS RESEARCH INST98 citations98
US5827737AOct 27, 1998
In vitro activation of cytotoxic T cells
SCRIPPS RESEARCH INST39 citations96
US5529921AJun 25, 1996
In vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and β2-microglobulin
SCRIPPS RESEARCH INST56 citations96
US5314813AMay 24, 1994
Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
SCRIPPS RESEARCH INST59 citations96
US6362001B1Mar 26, 2002
Method for producing a synthetic antigen presenting transformed Drosophila cell
SCRIPPS RESEARCH INST45 citations95
US6255073B1Jul 3, 2001
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST79 citations95
US6225042B1May 1, 2001
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST55 citations95
US6001365ADec 14, 1999
In vitro activation of cytotoxic T cells
SCRIPPS RESEARCH INST48 citations92
US6461867B1Oct 8, 2002
Synthetic antigen presenting matrix
SCRIPPS RESEARCH INST22 citations91
US6828150B2Dec 7, 2004
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST11 citations80
US6251627B1Jun 26, 2001
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST5 citations73
US7402430B2Jul 22, 2008
MHC class II antigen-presenting systems and methods for activating CD4+ T cells
SCRIPPS RESEARCH INST1 citations62
US7074617B1Jul 11, 2006
MHC class II antigen-presenting systems and methods for activatind CD4+T cells
SCRIPPS RESEARCH INST1 citations62
US7439335B2Oct 21, 2008
MHC class II antigen-presenting systems and methods for activating CD4+ T cells
SCRIPPS RESEARCH INST0 citations51
CAI ZELING
6 patentsUS8084256B2Dec 27, 2011
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING10 citations91
US8133728B2Mar 13, 2012
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8133726B2Mar 13, 2012
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8133972B2Mar 13, 2012
IgE antigenic peptides
CAI ZELING0 citations51
US8106153B2Jan 31, 2012
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8084253B2Dec 27, 2011
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
ORTHO MCNEIL PHARM INC
5 patentsUS7842501B2Nov 30, 2010
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
ORTHO MCNEIL PHARM INC25 citations95
US6107476AAug 22, 2000
Nucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growth
ORTHO MCNEIL PHARM INC24 citations92
US6372955B1Apr 16, 2002
Methods for Producing B cells and antibodies from H2-O modified transgenic mice
ORTHO MCNEIL PHARM INC23 citations91
US7125964B2Oct 24, 2006
Purification of antigen-specific T cells
ORTHO MCNEIL PHARM INC15 citations79
US6225525B1May 1, 2001
ATP-binding cassette transporter (ABC1) modified transgenic mice
ORTHO MCNEIL PHARM INC7 citations65